Japan to Adopt Generic Company Indices for Drug Pricing on Pilot Basis from FY2024

Chuikyo Drug Pricing Subcommittee Meeting on Nov. 17 The Japanese health ministry is now set for a pilot-based rollout of generic company evaluation indicators under the drug pricing system, beginning in FY2024. The new rule would basically give better prices...read more